The Bionics Institute is very pleased to announce the appointment of two new leadership roles.  The Chief Technology Officer (CTO) and Research Director will work in close collaboration with our CEO to drive the development of new and improved medical bionic technologies to transform people’s lives.

Our CTO, Professor Hugh McDermott, is a Fellow of the Institute of Electrical and Electronics Engineers (IEEE), the Acoustical Society of America (ASA), and the Australian Academy of Health and Medical Sciences (AAHMS).  With his extensive background in cochlear implant innovation, he brings over 35 years of experience in signal processing, clinical studies, and electronic design to our research programs.  Since joining the Bionics Institute in 2010, Hugh has been instrumental in the development of our deep brain stimulation system, which is aimed at improving therapy for people with movement disorders such as Parkinson’s disease. He continues to actively participate in clinical hearing research.

Our Research Director, Associate Professor James Fallon, heads the Institute’s internationally-recognised pre-clinical hearing research program.  Primarily focussing on improving outcomes for cochlear implant users, James is also heavily involved in our neurobionics and vision research streams.  He has a special interest in understanding how the brain changes with deafness and integrates electric and acoustic hearing. James is a well-respected mentor at the Institute and is actively involved in student supervision, with over 10 PhD candidates.